financetom
Business
financetom
/
Business
/
Campbell's Faces 'Persistent' Challenges in Snacks Business, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Campbell's Faces 'Persistent' Challenges in Snacks Business, Morgan Stanley Says
Jun 3, 2025 9:01 AM

11:38 AM EDT, 06/03/2025 (MT Newswires) -- Campbell's (CPB) could face muted organic sales growth on the back of struggling snacks business, Morgan Stanley said in a Tuesday note.

"We expect OSG to remain muted given persistent snacks category challenges," the report said.

"We believe protecting EPS in FY26 will be challenging should tariffs remain in place, while at the same time acknowledging compressed relative valuation vs. history."

The report said underlying OSG remained weak in Q3, down 1% on continued struggles in the snacks segment with 5% volume declines accelerating sequentially against last quarter's 2%.

While Campbell's will continue to benefit from cost saving efforts, the company will also face with headwinds such as tariffs and incentive compensation resetting, the report said.

Morgan Stanley now estimates the company's fiscal 2025 EPS at $2.90, down from $2.95 previously. It cut its price target on the stock to $35 from $40 while keeping its equal-weight rating.

Price: 33.75, Change: -0.50, Percent Change: -1.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PharmaCorp Rx Upsizes Bought-Deal Public Offering of Share Units to $20 Million
PharmaCorp Rx Upsizes Bought-Deal Public Offering of Share Units to $20 Million
Nov 6, 2025
12:55 PM EST, 11/06/2025 (MT Newswires) -- PharmaCorp Rx (PCRX.V) on Thursday said it is upsizing a bought-deal share offering to $20 million, up from its prior $15 million target. The company will now sell underwriters 47.7-million units priced at $0.42 apiece and made up of a share and one-half of a two-year warrant to buy a share for $0.50....
Market Chatter: SAP to Offer Concessions to Resolve EU Antitrust Probe
Market Chatter: SAP to Offer Concessions to Resolve EU Antitrust Probe
Nov 6, 2025
12:54 PM EST, 11/06/2025 (MT Newswires) -- SAP (SAP) is preparing to offer formal concessions to the European Commission to settle an antitrust investigation and avoid a potential hefty fine, Reuters reported Thursday, citing people familiar with the matter. The Commission is expected to seek feedback from rivals and customers before deciding on next steps, the people told Reuters. SAP...
HPSG's uLeadership Acquisition Deepens Its Investment in Nurse Leadership Development
HPSG's uLeadership Acquisition Deepens Its Investment in Nurse Leadership Development
Nov 6, 2025
PENSACOLA, Fla., Nov. 6, 2025 /PRNewswire/ -- Healthcare Plus Solutions Group® (HPSG)—a leader development and coaching firm founded by healthcare veterans and visionaries Quint Studer and Dan Collard—has acquired uLeadership®, a nationally and internationally recognized professional development and research company focused on relational leadership education for nurse leaders. The founders of uLeadership—Dr. Kay Kennedy, CEO; Dr. Lucy Leclerc, chief innovation and learning officer; and...
What's Going On With Marvell Technology Stock Today?
What's Going On With Marvell Technology Stock Today?
Nov 6, 2025
Shares of Marvell Technology, Inc. ( MRVL ) are rising Thursday following a news report about a potential sale of the semiconductor company. MRVL is biding its time at current levels. Get the latest updates here. What To Know: Japanese conglomerate SoftBank considered purchasing Marvell ( MRVL ) earlier in 2025, according to a Bloomberg report. The report indicates that SoftBank...
Copyright 2023-2026 - www.financetom.com All Rights Reserved